Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Cell Reports
|
August 4, 2023
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype
Estefania Cuesta-Borràs, Cándida Salvans, Oriol Arqués, et al.
Translational Oncology
|
April 9, 2023
Impact of the COVID-19 pandemic in the early-onset colorectal cancer
Iosune Baraibar, Ariadna García, Francesc Salvà, et al.
Nature Communications
|
August 8, 2024
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)
Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Jaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Critical Care (London, England)
|
September 19, 2008
Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial
Gisela Del Carmen De La Rosa, Jorge Hernando Donado, Alvaro Humberto Restrepo, et al.
BJC Reports
|
November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial
Marta Ligero, Jorge Hernando, Eric Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)
Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo, et al.
Medicina Intensiva
|
June 21, 2024
Association of dead space fraction to mortality in patients with COVID-19-related ARDS: A historical cohort observational study
Carlos Carvajal, Nelson Darío Giraldo Ramirez, Andrés David De La Hoz Castro, et al.
Endocrine-Related Cancer
|
June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs
Louis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Cell Reports
|
August 4, 2023
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype
Estefania Cuesta-Borràs, Cándida Salvans, Oriol Arqués, et al.
Translational Oncology
|
April 9, 2023
Impact of the COVID-19 pandemic in the early-onset colorectal cancer
Iosune Baraibar, Ariadna García, Francesc Salvà, et al.
Nature Communications
|
August 8, 2024
Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)
Maria Carmen Riesco-Martinez, Jaume Capdevila, Vicente Alonso, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Jaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Critical Care (London, England)
|
September 19, 2008
Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial
Gisela Del Carmen De La Rosa, Jorge Hernando Donado, Alvaro Humberto Restrepo, et al.
BJC Reports
|
November 8, 2024
Radiomics and outcome prediction to antiangiogenic treatment in advanced gastroenteropancreatic neuroendocrine tumours: findings from the phase II TALENT trial
Marta Ligero, Jorge Hernando, Eric Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)
Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo, et al.
Medicina Intensiva
|
June 21, 2024
Association of dead space fraction to mortality in patients with COVID-19-related ARDS: A historical cohort observational study
Carlos Carvajal, Nelson Darío Giraldo Ramirez, Andrés David De La Hoz Castro, et al.
Endocrine-Related Cancer
|
June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETs
Louis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Page
of 10